pGM169/GL67A
- Generic Name
- pGM169/GL67A
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Repeated Application of Gene Therapy in CF Patients
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2015-10-22
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 130
- Registration Number
- NCT01621867
- Locations
- 🇬🇧
Royal Hospital for Sick Children, Edinburgh, United Kingdom
🇬🇧Western General Hospital, Edinburgh, United Kingdom
🇬🇧Royal Brompton Hospital, London, United Kingdom
Single Dose of pGM169/GL67A in CF Patients
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 35
- Registration Number
- NCT00789867
- Locations
- 🇬🇧
Royal Brompton Hospital, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath